Contact
Please use this form to send email to PR contact of this press release:
KAER Biotherapeutics Awarded NIH Grant to develop SUPRAER® Surfactant Aerosol Therapy for Neonatal Respiratory Distress
TO:
Donovan Yeates, CEO
KAER Biotherapeutics
+1 760-480-9400